Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update

SmartPros Ltd. (SPRO) Tops Q4 EPS

March 30, 2023 4:37 PM EDT

SmartPros Ltd. (NASDAQ: SPRO) reported Q4 EPS of $0.55, $0.90 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $47.4 thousand versus the consensus estimate of $866.67 thousand.

For earnings history and earnings-related data on SmartPros Ltd. (SPRO) click here.

... More